Skip to search.
 TSX Down 0.28% TSX Ventures Down 0.57%

More On ISIS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
57.56 Down 0.28(0.48%) Dec 21, 4:00PM EST - Nasdaq Real Time Price
Prev Close:57.56
Open:57.56
Bid:N/A
Ask:N/A
1y Target Est:65.11
Beta:1.89939
Next Earnings Date:N/A
Day's Range:56.70 - N/A
52wk Range:37.38 - 77.80
Volume:998,037
Avg Vol (3m):1,722,070
Market Cap:6.91B
P/E (ttm):483.70
EPS (ttm):0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISDown 0.48%6.91B
ENZDown 0.88%235.26M
SRPTUp 2.94%2.85B
GILDDown 1.04%106.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback